D-0772-2021 Class I Terminated

Recalled by KVK-Tech, Inc. — Newtown, PA

FDA drug recall D-0772-2021 was initiated by KVK-Tech, Inc. on Jul 2, 2021 and is designated Class I. Reason for recall: Temperature abuse: the firm received customer complaints of unusual grittiness in the product. The recall status is terminated (terminated May 23, 2022). Affected quantity: 1,692 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 1, 2021
Initiation Date
Jul 2, 2021
Termination Date
May 23, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,692 bottles

Product description

Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-223-21.

Reason for recall

Temperature abuse: the firm received customer complaints of unusual grittiness in the product.

Distribution pattern

Product was distributed to one distributor who may have further distributed Nationwide in the USA.

Code information

Batch # 16653A, 16654A, Exp 12/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0772-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0772-2021. Report a data issue: hello@regdatalab.com.